(R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE 基本信息
MSDS 用途與合成方法 (R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE價格(試劑級) 上下游產(chǎn)品信息
中文名稱 | (R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE |
---|---|
中文同義詞 | GYKI 47409;化合物 BDZ-G;(R)-2-甲基-4-(8-甲基-7-(5-甲基-1,3,4-噻二唑-2-基)-8,9-二氫-7H-[1,3]二氧戊環(huán)[4',5':4,5]苯并[1,2-D][1,2]二氮雜卓-5-基)苯胺;化合物BDZ-G,10 MM DMSO 溶液 |
英文名稱 | BDZ-g,GYKI 47409, |
英文同義詞 | BDZ-g,GYKI 47409,;AMPA/kainate antagonist-3;Benzenamine, 4-[(8R)-8,9-dihydro-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-7H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-5-yl]-2-methyl-;GYKI47409;kainate antagonist-3;(R)-5-(4-amino-3-methyl-phenyl)-8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-1,3-dioxolo[4,5-h][2,3]-benzodiazepine,(R)-5-(4-amino-3-;BDZ-g;(R)-2-Methyl-4-(8-methyl-7-(5-methyl-1,3,4-thiadiazol-2-yl)-8,9-dihydro-7H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d][1,2]diazepin-5-yl)aniline |
CAS號 | 732278-52-3 |
分子式 | C21H21N5O2S |
分子量 | 407.49 |
EINECS號 | |
相關(guān)類別 | |
Mol文件 | 732278-52-3.mol |
結(jié)構(gòu)式 | ![]() |
(R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE 性質(zhì)
形態(tài) | 固體 |
---|---|
顏色 | 白色至黃色 |
安全信息
更新日期 | 產(chǎn)品編號 | 產(chǎn)品名稱 | CAS號 | 包裝 | 價格 |
---|---|---|---|---|---|
2025/02/08 | HY-129030 | BDZ-g | 732278-52-3 | 1 mg | 1540元 |
2025/02/08 | HY-129030 | (R)-5-(4-AMINO-3-METHYL-PHENYL)-8-METHYL-7-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-8,9-DIHYDRO-7H-1,3-DIOXOLO[4,5-H][2,3]-BENZODIAZEPINE BDZ-g | 732278-52-3 | 5 mg | 4305元 |